Integromics | GenomeWeb

Integromics

Integromics has released a new version of RealTime StatMiner, its software for analyzing data from qPCR experiments.

Integromics has released version 5.0 of its RealTime StatMiner software for qPCR gene expression workflows.

Integromics has released OmicsOffice 5, the latest version of its software for analyzing and integrating genomic data.

NEW YORK (GenomeWeb News) – PerkinElmer has signed an agreement with Integromics to become the sole worldwide distributor of Integromics' OmicsOffice, a software suite that provides tools for analyzing and integrating data from different genomics technologies.

NEW YORK (GenomeWeb News) – Integromics today announced a partnership with two Spanish organizations to develop new data analysis methods for clinical genomic studies.

NEW YORK (GenomeWeb News) – Spanish bioinformatics firm Integromics said today that it has joined an EU-funded consortium that is developing new methods for managing massive genomics data sets and trying to make them more useful in the clinical realm.

Cautious optimism seems to be the prevailing mood among some of the bioinformatics vendors that have signed up to develop analysis tools for Illumina’s BaseSpace applications store.

Ahram Biosystems this week launched the Palm PCR F1-12, an economy model of its portable PCR system.

Integromics recently introduced OmicsOffice, a software tool for the analysis of data from quantitative PCR, microarray, and next-generation sequencing platforms. The company said it will begin selling the tool next month.

Integromics next month will release OmicsOffice, a software tool that combines Integromics' software solutions for analyzing next-gen sequencing data, qPCR data, and microarray data.

Pages

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.